Effects of combination therapy of dexamethasone and fluoxetine on levels of interleukin-1β and interleukin-6 in a rat model of asthma with depressive-like behaviors

HealthMED

Volumn 6, Issue 6, 2012, Pages 1998-2003

  Li, Chengde ^a   Mao, Shumei ^a   Wang, Yuliang ^a   Sun, Hongwei ^a  

^a WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

Asthma; Depressive like behaviors; Dexamethasone; Effect; Fluoxetine; Interleukin 1 ; Interleukin 6

Indexed keywords

DEXAMETHASONE; FLUOXETINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; SUCROSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; DEPRESSION; DISEASE MODEL; DRUG EFFECT; DRUG MECHANISM; LUNG ALVEOLUS CELL; LUNG LAVAGE; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; STRESS;

EID: 84865446187     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Goodwin RD, Jacobi F, Thefeld W. Mental disorders and asthma in the community. Arch Gen Psychiatry 2003; 60:1125-1130.
2. Katon W, Lozano P, Russo J, et al: The prevalence of DSM-IV anxiety and depressive disorders in youth with asthma compared with controls. J Adolesc Health 2007; 41: 455-463.
3. Yuping Song, Hongwei Sun, Yuying Sun, et al: A study on relationship between coping style, social support and bronchial asthma patients with depression. China Journal of Health Psychology 2008; 162: 226-227.
4. Lappalainen U, Whitsett JA, Wert SE, et al: Interleukin-1 causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 2005; 32: 312-318.
5. Neveu WA, Allard JL, Raymond DM, et al: Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function. Respir Res 2010 Mar 8; 11: 28.
6. Yu YW, Chen TJ, Hong CJ, et al: Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology 2003; 28: 1182-1185.
7. Prather AA, Rabinovitz M, Pollock BG, et al: Cytokine-induced depression during IFN-α treatment: the role of IL-6 and sleep quality. Brain Behav Immun. 2009; 23: 1109-1116.
8. Willner P, Towell A, Sampson D, et al: Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 1987; 93: 358-364.
9. Rayen I, van den Hove DL, Prickaerts J, et al: Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS One 2011; 6: e24003.
10. Wei B, Zhang H, Li L, et al: T helper 17 cells and regulatory T-cell imbalance in paediatric patients with asthma. J Int Med Res. 2011; 4:1293-1305.
11. Lavoie KL, Bacon SL, Barone S, et al: What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both? Chest 2006; 130: 1039-1047.
12. Johnson VJ, Yucesoy B, Luster MI. Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-Induced asthma. J Allergy Clin Immunol 2005; 116: 851-858.
13. Lappalainen U, Whitsett JA, Wert SE, et al: Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 2005; 32: 311-318.
14. Wanderer AA. Interleukin-1β targeted therapy in severe persistent asthma (SPA) and chronic obstructive pulmonary disease (COPD): proposed similarities between biphasic pathobiology of SPA/COPD and ischemia-reperfusion injury. IMAJ 2008, 10: 837-842.
15. Levine J, Barak Y, Chengappa KN, et al: Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 1999; 40: 171-176.
16. Owen BM, Eccleston D, Ferrier IN, et al: Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand 2001; 103: 226-228.
17. Kagaya A, Kugaya A, Takebayashi M, et al: Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan. Neuropsychobiology 2001; 43: 59-62.
18. Groer MW, Morgan K. Immune, health and endocrine characteristics of depressed postpartum mothers. Psychoneuroendocrinology 2007; 32: 133-139.
19. Penninx BW, Kritchevsky SB, Yaffe K, et al: Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 2003; 54: 566-572.
20. Marques-deak AH, Neto FL, Dominguez WV, et al: Cytokine profiles in women with different subtypes of major depressive disorder. J Psychiatr Res 2007, 41: 152-159.
21. J. Podlipný, Z. Hess, J. Vrzalová, H., et al: Lower Serum levels of interleukin-6 in a population sample with symptoms of depression than in a population sample without symptoms of depression. Physiol Res 2010; 59: 121-126.